<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-23175</identifier>
<setSpec>0212-8799</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Blood and eritropoietin doping. Secondary effects</dc:title>
<dc:creator>Berglund, B</dc:creator>
<dc:language>es</dc:language>
<dc:publisher>Federación Española de Medicina del Deporte</dc:publisher>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Arch. med. deporte;17(78): 355-358, jul. 2000.</dc:source>
<dc:identifier>ibc-23175</dc:identifier>
<dc:title xml:lang="es">Efectos secundarios del dopaje de sangre y de eritropoyetina</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d1821^s22021</dc:subject>
<dc:subject>^d29387^s22020</dc:subject>
<dc:subject>^d29387^s22062</dc:subject>
<dc:subject>^d1831</dc:subject>
<dc:subject>^d29625</dc:subject>
<dc:subject>^d3982</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d10281^s22021</dc:subject>
<dc:subject>^d4360</dc:subject>
<dc:type>article</dc:type>
<dc:date>200007</dc:date>
</metadata>
</record>
</ibecs-document>
